Pre-treatment with ozonized oxygen (O3) aggravates inflammation in septic rats

Inflammation Research

Volumn 53, Issue SUPPL. 2, 2004, Pages

  Torossian, A ^a   Ruehlmann, S ^a   Eberhart, L ^a   Middeke, M ^a   Wulf, H ^a   Bauhofer, A ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

Clinic modelling randomized trials; Cytokines; Ozone (O3); Peritoneal contamination and infection; Sepsis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; OZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; INFLAMMATION; MALE; MORTALITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 4344715924     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-0352-7     Document Type: Article

References (27)

1. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci 1999; 56: 270-9.
2. Schmidt JM. The meaning of the sixth edition of 'Organon der Heilkunst'. Arch Hist Filoz Med 2002; 65: 491-8.
3. Bauhofer A, Huttel M, Reimund K-P, Celik I, Greger B, Lorenz W. Effective prophylaxis with rhG-CSF in abdominal sepsis: a new mechanism improving the antimicrobial functions of granulocytes (Wirksame Prophylaxe mit rhG-CSF bei abdomineller Sepsis: Verbesserung der antimikrobiellen Funktion von Granulozyten als neuer Mechanismus in vivo). Langenbecks Arch Chir Forum 1997; 593-6.
4. Lundblad R, Nesland JM, Giercksky K-E. Granulocyte colony-stimulating factor improves survival rate and reduces concentration of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med 1996; 24: 820-6.
5. Gupta M. A critical appraisal of evidence-based medicine: some ethical considerations. J Eval Clin Pract 2003; 9: 111-21.
6. Caspi O, Sechrest L, Pitluk HC, Marshall CL, Bell IR. Nichter M. On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives. Altern Ther Health Med 2003; 9: 58-62.
7. Nathan C. Immunology. Catalytic antibody bridges innate and adaptive immunity. Science 2002; 298: 2143-4.
8. Wentworth P Jr, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002; 298: 2195-9.
9. Schulz S, Rodriguez ZZ, Mutters R, Menendez S, Bette M. Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur Surg Res 2003; 35: 26-34.
10. Lorenz W, Reimund K-P, Weitzel F, Celik I, Kurnatowski M, Schneider C et al. Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 1994; 116: 925-34.
11. Bauhofer A, Lorenz W, Celik I, Stinner B, Solovera J, Lorijn R. Haematopoetic cytokines, G-CSF and abdominal surgery. In: Schein, M., Wise, L., eds. Cytokines and the abdominal surgeon. 1998; 117-41.
12. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 1985; 2nd: 1-302.
13. Burleson GR, Keyes LL, Stutzman JD. Immunosuppression of pulmonary natural killer activity by exposure to ozone. Immunopharmacol Immunotoxicol 1989; 11: 715-35.
14. Ishii Y, Yang H, Sakamoto T, Nomura A, Hasegawa S, Hirata F et al. Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure. Toxicol Appl Pharmacol 1997; 147: 214-23.
15. Kudriavtsev EP, Miroshin SI, Semenov SV, Snigorenko AS, Sidorovich IA. Ozone therapy of diffuse peritonitis in the early postoperative period. Khirurgiia (Mosk) 1997; 36-41.
16. Ozmen V, Thomas WO, Healy JT, Fish JM, Chambers R, Tacchi E et al. Irrigation of the abdominal cavity in the treatment of experimentally induced microbial peritonitis: efficacy of ozonated saline. Am Surg 1993; 59: 297-303.
17. Oberholzer A, Oberholzer C, Moldaver L. Sepsis syndromes: Understanding the role of innate and aquired immunity. Shock 2001; 16: 83-96.
18. Edmiston CE Jr, Goheen MP, Kornhall S, Jones FE, Condon RE. Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 1990; 14: 176-83.
19. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331-5.
20. Torossian A, Ruehlmann S, Middeke M, Sessler DI, Lorenz W, Wulf HF et al. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor. Anesthesiology 2003; 99: 1087-92.
21. Ishikura H, Uedono Y, Yamagami K, Arai T, Takeyama N, Tanaka T. Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis. Surg Today 1996; 26: 694-9.
22. Margalit M, Attias E, Attias D, Elstein D, Zimran A, Matzner Y. Effect of ozone on neutrophil function in vitro. Clin Lab Haematol 2001; 23: 243-7.
23. Fievez L, Kirschvink N, Dogne S, Jaspar F, Merville MP, Bours V et al. Impaired accumulation of granulocytes in the lung during ozone adaptation. Free Radic Biol Med 2001; 31: 633-41.
24. Zhao Q, Simpson LG, Driscoll KE, Leikauf GD. Chemokine regulation of ozone-induced neutrophil and monocyte inflammation. Am J Physiol 1998; 274: L39-46.
25. Kalyanaraman M, Heidemann SM, Sarnaik AP. Macrophage inflammatory protein-2 predicts acute lung injury in endotoxemia. J Investig Med 1998; 46: 275-8.
26. Bishop MR, Tarantolo SR, Geller RB, Lynch JC, Bierman PJ, Pavletic ZS et al. A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood 2000; 96: 80-5.
27. Weiss M, Gross-Weege W, Schneider M, Neidhardt H, Liebert S, Mirow N et al. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 1995; 10: 21-6.